These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 9811333

  • 1. MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas.
    Zietz C, Rössle M, Haas C, Sendelhofert A, Hirschmann A, Stürzl M, Löhrs U.
    Am J Pathol; 1998 Nov; 153(5):1425-33. PubMed ID: 9811333
    [Abstract] [Full Text] [Related]

  • 2. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA, Huang L, Berger D, Chang H, Klein-Szanto AJ, Goodrow T, Wood M, Obara T, Heath CW, Lynch H.
    Cancer; 1997 Feb 15; 79(4):700-16. PubMed ID: 9024708
    [Abstract] [Full Text] [Related]

  • 3. p53/MDM-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: a ten-year follow-up study.
    Stefanou DG, Nonni AV, Agnantis NJ, Athanassiadou SE, Briassoulis E, Pavlidis N.
    Anticancer Res; 1998 Feb 15; 18(6B):4673-81. PubMed ID: 9891539
    [Abstract] [Full Text] [Related]

  • 4. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Giatromanolaki A, Koukourakis MI, Kakolyris S, Turley H, O'Byrne K, Scott PA, Pezzella F, Georgoulias V, Harris AL, Gatter KC.
    Clin Cancer Res; 1998 Dec 15; 4(12):3017-24. PubMed ID: 9865915
    [Abstract] [Full Text] [Related]

  • 5. mdm-2 expression correlates with wild-type p53 status in esophageal adenocarcinoma.
    Soslow RA, Altorki NK, Yang G, Xie D, Yang CS.
    Mod Pathol; 1999 Jun 15; 12(6):580-6. PubMed ID: 10392633
    [Abstract] [Full Text] [Related]

  • 6. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma.
    Pal S, Datta K, Mukhopadhyay D.
    Cancer Res; 2001 Sep 15; 61(18):6952-7. PubMed ID: 11559575
    [Abstract] [Full Text] [Related]

  • 7. MDM-2 oncoprotein overexpression in laryngeal squamous cell carcinoma: association with wild-type p53 accumulation.
    Pruneri G, Pignataro L, Carboni N, Luminari S, Capaccio P, Neri A, Buffa R.
    Mod Pathol; 1997 Aug 15; 10(8):785-92. PubMed ID: 9267820
    [Abstract] [Full Text] [Related]

  • 8. Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer.
    Fujiwaki R, Hata K, Iida K, Maede Y, Watanabe Y, Koike M, Miyazaki K.
    Acta Obstet Gynecol Scand; 1999 Sep 15; 78(8):728-34. PubMed ID: 10468067
    [Abstract] [Full Text] [Related]

  • 9. P53 expression in Reed-Sternberg cells does not correlate with gene mutations in Hodgkin's disease.
    Elenitoba-Johnson KS, Medeiros LJ, Khorsand J, King TC.
    Am J Clin Pathol; 1996 Dec 15; 106(6):728-38. PubMed ID: 8980348
    [Abstract] [Full Text] [Related]

  • 10. Mutant p53 in bone marrow stromal cells increases VEGF expression and supports leukemia cell growth.
    Narendran A, Ganjavi H, Morson N, Connor A, Barlow JW, Keystone E, Malkin D, Freedman MH.
    Exp Hematol; 2003 Aug 15; 31(8):693-701. PubMed ID: 12901974
    [Abstract] [Full Text] [Related]

  • 11. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
    Fontanini G, Boldrini L, Calcinai A, Chinè S, Lucchi M, Mussi A, Angeletti CA, Basolo F, Bevilacqua G.
    Clin Cancer Res; 1999 Jan 15; 5(1):155-61. PubMed ID: 9918214
    [Abstract] [Full Text] [Related]

  • 12. Expression of vascular endothelial growth factor (VEGF) in non-small cell lung cancer (NSCLC): association with p53 gene mutation and prognosis.
    Niklińska W, Burzykowski T, Chyczewski L, Nikliński J.
    Lung Cancer; 2001 Dec 15; 34 Suppl 2():S59-64. PubMed ID: 11720743
    [Abstract] [Full Text] [Related]

  • 13. Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen.
    Catalano A, Romano M, Martinotti S, Procopio A.
    Oncogene; 2002 Apr 25; 21(18):2896-900. PubMed ID: 11973650
    [Abstract] [Full Text] [Related]

  • 14. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
    Rieske P, Bartkowiak JK, Szadowska AM, Olborski B, Harezga-Bal B, Debiec-Rychter M.
    J Exp Clin Cancer Res; 1999 Sep 25; 18(3):403-16. PubMed ID: 10606188
    [Abstract] [Full Text] [Related]

  • 15. The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer.
    Linderholm BK, Lindahl T, Holmberg L, Klaar S, Lennerstrand J, Henriksson R, Bergh J.
    Cancer Res; 2001 Mar 01; 61(5):2256-60. PubMed ID: 11280795
    [Abstract] [Full Text] [Related]

  • 16. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
    Abu-Jawdeh GM, Faix JD, Niloff J, Tognazzi K, Manseau E, Dvorak HF, Brown LF.
    Lab Invest; 1996 Jun 01; 74(6):1105-15. PubMed ID: 8667614
    [Abstract] [Full Text] [Related]

  • 17. Expression of vascular endothelial growth factor and its receptors during lung carcinogenesis by N-nitrosobis(2-hydroxypropyl)amine in rats.
    Takahama M, Tsutsumi M, Tsujiuchi T, Kido A, Sakitani H, Iki K, Taniguchi S, Kitamura S, Konishi Y.
    Mol Carcinog; 1999 Apr 01; 24(4):287-93. PubMed ID: 10326865
    [Abstract] [Full Text] [Related]

  • 18. Malignant mixed Müllerian tumors of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 44 cases.
    Blom R, Guerrieri C, Stâl O, Malmström H, Sullivan S, Simonsen E.
    Gynecol Oncol; 1998 Jan 01; 68(1):18-24. PubMed ID: 9454654
    [Abstract] [Full Text] [Related]

  • 19. Expression of vascular endothelial growth factor, mitogen-activated protein kinase and p53 in human colorectal cancer.
    Cassano A, Bagalà C, Battelli C, Schinzari G, Quirino M, Ratto C, Landriscina M, Barone C.
    Anticancer Res; 2002 Jan 01; 22(4):2179-84. PubMed ID: 12174901
    [Abstract] [Full Text] [Related]

  • 20. p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers.
    Hollstein M, Marion MJ, Lehman T, Welsh J, Harris CC, Martel-Planche G, Kusters I, Montesano R.
    Carcinogenesis; 1994 Jan 01; 15(1):1-3. PubMed ID: 8293534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.